Testing effectiveness (Phase 2)Study completedNCT00095940
What this trial is testing
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
Who this might be right for
Recurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Brain Stem GliomaRecurrent Childhood Ependymoma+5 more
National Cancer Institute (NCI) 52